Discount Agreement for Fesoterodin
DAK-Gesundheit is entering into non-exclusive discount agreements for the active ingredient Fesoterodin. This allows all interested pharmaceutical companies to participate from August 2026 to July 2028 (with an extension option).
CONTRACTING AUTHORITY
CLASSIFICATION
Procedure Type
Open Procedure
Contract Type
Supplies
Main CPV
33600000, Pharmaceutical products.
ADDITIONAL DETAILS
Legal Basis
32014L0024
DEADLINES & TIMELINE
Submission Deadline
1083 days remaining(LOT-0001)
Published